Cargando...
The therapy of congenital myasthenic syndromes
Congenital myasthenic syndromes (CMSs) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more mechanisms. Specific diagnosis of a CMS is important as some medications that benefit one type of CMS can be detrimental in another type. In some...
Guardado en:
Autor principal: | |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1978489/ https://ncbi.nlm.nih.gov/pubmed/17395135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2007.01.001 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|